Effect of Inspired Oxygen Concentration on Postoperative Atelectasis After VATS Lobectomy
1 other identifier
interventional
100
1 country
1
Brief Summary
This study aims to investigate whether using 50% FiO₂ during one-lung ventilation, compared with 100% FiO₂, reduces postoperative atelectasis in the non-dependent (healthy) lung of patients undergoing VATS pulmonary lobectomy, based on individualized PEEP titration. This is a single-center, prospective, assessor- and patient-blinded randomized controlled trial. A total of 100 patients (50 per group, including a pilot phase of 10 per group) will be enrolled and randomized 1:1 to the high-oxygen group (FiO₂=100%) and the low-oxygen group (FiO₂=50%). The primary endpoint is the percentage of atelectasis volume in the non-operated lung relative to the total non-operated lung volume, assessed by CT at 60±10 minutes after tracheal extubation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2026
CompletedFirst Posted
Study publicly available on registry
July 23, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
August 19, 2026
July 1, 2026
1.2 years
July 18, 2026
August 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Non-operated lung atelectasis volume percentage
Chest CT at 60±10 minutes after tracheal extubation
CT scans were performed at 60 ± 10 minutes after tracheal extubation to assess the volume ratio of atelectasis in the contralateral lung.
Secondary Outcomes (8)
Incidence of postoperative pulmonary complications
Postoperative days 1-3
QoR-15 quality of recovery score
Postoperative days 1-3
Arterial blood gas analysis (oxygenation index)
Multiple time points: (1) preoperative preparation room; (2) 5 minutes after two-lung ventilation at induction; (3) 5 minutes after one-lung ventilation start; (4) 1 hour after one-lung ventilation; (5) 10 minutes after tracheal extubation
Intraoperative oxygen saturation
Intraoperative (during one lung ventilation)
Oxygen concentration exposure burden
Intraoperative (during one lung ventilation)
- +3 more secondary outcomes
Study Arms (2)
High-Oxygen Group (FiO₂=100%)
ACTIVE COMPARATORFiO₂=100% throughout one-lung ventilation.
Low-Oxygen Group (FiO₂=50%)
EXPERIMENTALInitial FiO₂=50% during one-lung ventilation (maintaining SpO₂≥92%) with individualized PEEP titration. If SpO₂\<92%, increase FiO₂ by 10% increments; if SpO₂\<90% and FiO₂ already at 100%, initiate rescue ventilation.
Interventions
Ventilation with initial FiO₂=50% during one-lung ventilation, combined with individualized PEEP titration. Oxygen concentration is dynamically adjusted based on SpO₂; ventilation duration at each FiO₂ level and total oxygen exposure burden are recorded.
Ventilation with FiO₂=100% throughout one-lung ventilation, combined with individualized PEEP titration (decremental PEEP titration selecting the highest PEEP corresponding to the lowest driving pressure).
Eligibility Criteria
You may qualify if:
- Age 18-65 years Elective thoracoscopic (VATS) pulmonary lobectomy Anticipated one-lung ventilation duration \>1 hour ASA physical status I-III
You may not qualify if:
- Previous pulmonary surgery (including lobectomy, lung volume reduction surgery, or other lung resection) Pre-existing significant atelectasis (large collapse on preoperative CT) Contraindications to PEEP: intracranial hypertension, bronchopleural fistula, hypovolemic shock, right heart failure, giant bullae, pneumothorax Preoperative continuous oxygen therapy or mechanical ventilation, moderate-severe COPD BMI ≥ 30 kg/m² Ischemic cardiovascular and cerebrovascular diseases, such as myocardial infarction, ischemic stroke, and patients with coronary or cerebrovascular stents Patient refusal to participate
- Withdrawal Criteria / Major Protocol Deviations:
- Surgery changed to simple wedge resection Severe pleural adhesions (found intraoperatively) One-lung ventilation duration \< 50 minutes Intraoperative blood loss \> 500 ml Severe hypotension (MAP \< 55 mmHg despite high-dose vasopressors) Unexpected non-thoracic surgical procedure Ventilation protocol interrupted (e.g., FiO₂ exposure \< 80% of planned time in the low-oxygen group) Postoperative CT not completed or image quality unusable Subject withdrawal of informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology, Peking University People's Hospital
Beijing, Beijing Municipality, 100000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Patients are blinded pre- and postoperatively; postoperative data collectors, CT readers, and biostatisticians are blinded to allocation; only the attending anesthesiologist is unblinded due to the nature of the intervention (setting FiO₂), but does not participate in data collection or outcome assessment
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Anesthesiology
Study Record Dates
First Submitted
July 18, 2026
First Posted
July 23, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
August 19, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Immediately following publication, for 3 years
- Access Criteria
- Researchers with a reasonable research purpose, subject to a data use agreement
De-identified individual participant data will be available upon reasonable request after publication